(Q43650825)

25 November 2017

title

Effects of antiepileptic drugs on cognition (English)

1 reference

25 November 2017

A P Aldenkamp

1

1 reference

25 November 2017

publication date

1 January 2001

1 reference

25 November 2017

1 reference

25 November 2017

volume

42 Suppl 1

1 reference

25 November 2017

page(s)

46-9, discussion 50-1

1 reference

Psychotropic effects of carbamazepine in epilepsy: A double-blind comparison with phenytoin

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Memory impairment in epileptic patients: selective effects of phenobarbital concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Effects of Diphenylhydantoin on Mental Abilities in the Elderly†

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Effects of carbamazepine and phenytoin on EEG and memory in healthy adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Withdrawal of antiepileptic medication in children--effects on cognitive function: The Multicenter Holmfrid Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Sodium valproate and cognitive functioning in normal volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Comparative cognitive effects of anticonvulsants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

A controlled comparison of the effects of diphenylhydantoin and placebo on mood and psychomotor functioning in normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive effects of anticonvulsant monotherapy in elderly patients: a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Side effects of sodium valproate in monotherapy controlled by plasma levels: a study in 88 pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Effects of carbamazepine on psychomotor performance in children as a function of drug concentration, seizure type, and time of medication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Controlled release carbamazepine: cognitive side effects in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Pharmacokinetics and cognitive effects of carbamazepine formulations with different dissolution rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Behavioral and cognitive effects of lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Memory and psychomotor effects of oxcarbazepine in healthy human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Effects of gabapentin on cognition and quality of life in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1528-1157.2001.00516.X

10.1046/J.1528-1157.2001.00516.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference